专利检索 ap:("Bayer Schering Pharma AG") AND inv:"PETERS, Olaf" 第 1 页

1.

发明公开
N-(1-HETARYLPIPERIDIN-4-YL)(HET)ARYLAMIDES AS EP2 RECEPTOR MODULATORS 审中-公开
标题翻译： N-（1- HETARYLPIPERIDIN -4-基）（HET）芳基酰胺AS EP2受体的调节剂

公开(公告)号：EP2066654A1

公开(公告)日：2009-06-10

申请号：EP07802347.0

申请日：2007-09-06

申请人： Bayer Schering Pharma AG

发明人： BRÄUER, Nico , BUCHMANN, Bernd , KOPPITZ, Marcus , TER LAAK, Antonius , LANGER, Gernot , LINDENTHAL, Bernhard , PETERS, Olaf , WINTERMANTEL, Tim

IPC分类号： C07D401/04 , C07D215/46 , C07D401/14 , C07D405/14 , C07D409/14 , C07D403/04 , C07D403/14 , A61K31/4709 , A61K31/4706 , A61K31/472 , A61K31/4725 , A61K31/517 , A61P19/10

CPC分类号： C07D401/04 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/14 , C07D409/14

摘要： The present invention relates to (het)aryl-3-[(het)arylpiperidin-4-yl]amides, to processes for their preparation and to their use for producing pharmaceutical compositions for treatment of disorders and indications connected to the EP2 receptor.